Japanese Bitcoin treasury company Metaplanet has revised its outlook upward, expecting 2025 revenue of about 5.8 billion yen or $58 million and operating profit of about $40 million. The firm anticipates 2026 revenue to rise to approximately $103 million, with operating profit expected to be around $73 million. However, a drop in Bitcoin prices will trigger non-cash impairment charges of $680 to $700 million in 2025, leading to steep reported losses. Metaplanet’s Bitcoin holdings jumped to 35,102 coins.
CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
Story Highlights The live price of the CRV token is . Price predictions for 2026…
One of the defining qualities of crypto traders is that they spend many hours learning…
Injective price is showing renewed strength following Coinbase integration, with the exchange's native INJ support…
A new standard for evaluating altcoins could be emerging. This comes as institutional attention is…
India's Parliamentary Standing Committee on Finance has recommended an interim regulatory framework for cryptocurrencies through…
Injective (INJ) price has entered a decisive phase after spending several weeks consolidating beneath the…
